CYPHERPUNK TECHNOLOGIES INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$2.46 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-12
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$881.00K, a 190.92% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$1.57M.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was -$4.75M.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$6.27M.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was -$10.42M, a 1255.32% decline from fiscal 2024.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $902.00K, a 26.69% increase from fiscal 2023.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $712.00K, a 24.66% decline from fiscal 2022.
- CYPHERPUNK TECHNOLOGIES INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $945.00K, a 75.77% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$881.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$2.46M 10-Q · filed 2026-08-12 | -$7.21M derived: sum of 3 quarters · filed 2026-08-12 | -$13.47M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$1.57M 10-Q · filed 2026-05-14 | -$6.32M derived: sum of 2 quarters · filed 2026-05-14 | -$12.59M derived: sum of 3 quarters · filed 2026-05-14 | -$11.62M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$11.02M derived: sum of 2 quarters · filed 2026-03-16 | -$10.05M derived: sum of 3 quarters · filed 2026-08-12 | -$10.42M 10-K · filed 2026-03-16 |
| 2025-09-30 | -$6.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$5.30M derived: sum of 2 quarters · filed 2026-08-12 | -$5.67M 10-Q · filed 2025-11-12 | -$7.34M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $969.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $596.00K 10-Q · filed 2026-08-12 | -$1.07M derived: sum of 3 quarters · filed 2026-08-12 | -$1.19M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$373.00K 10-Q · filed 2026-05-14 | -$2.04M derived: sum of 2 quarters · filed 2026-05-14 | -$2.16M derived: sum of 3 quarters · filed 2026-05-14 | $2.92M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$1.78M derived: sum of 2 quarters · filed 2026-03-16 | $3.29M derived: sum of 3 quarters · filed 2026-03-16 | $902.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | -$114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.96M derived: sum of 2 quarters · filed 2025-11-12 | $2.57M 10-Q · filed 2025-11-12 | $4.29M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $5.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $2.69M 10-Q · filed 2025-08-14 | $4.41M derived: sum of 3 quarters · filed 2025-08-14 | $3.78M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$2.39M 10-Q · filed 2025-05-13 | -$668.00K derived: sum of 2 quarters · filed 2025-05-13 | -$1.29M derived: sum of 3 quarters · filed 2025-05-13 | $522.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $1.09M derived: sum of 2 quarters · filed 2025-03-26 | $2.91M derived: sum of 3 quarters · filed 2025-03-26 | $712.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | -$624.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.19M derived: sum of 2 quarters · filed 2024-11-13 | -$1.01M 10-Q · filed 2024-11-13 | -$2.23M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$382.00K 10-Q · filed 2024-08-12 | -$1.60M derived: sum of 3 quarters · filed 2024-08-12 | -$116.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$2.20M 10-Q · filed 2024-05-13 | -$3.42M derived: sum of 2 quarters · filed 2024-05-13 | -$1.93M derived: sum of 3 quarters · filed 2024-05-13 | $1.12M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $266.00K derived: sum of 2 quarters · filed 2024-03-18 | $3.31M derived: sum of 3 quarters · filed 2024-03-18 | $945.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $4.54M derived: sum of 2 quarters · filed 2023-11-13 | $2.17M 10-Q · filed 2023-11-13 | $1.19M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $3.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $679.00K 10-Q · filed 2023-08-14 | -$294.00K derived: sum of 3 quarters · filed 2023-08-14 | $3.09M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$2.37M 10-Q · filed 2023-05-15 | -$3.34M derived: sum of 2 quarters · filed 2023-05-15 | $44.00K derived: sum of 3 quarters · filed 2023-05-15 | $1.15M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$973.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $2.41M derived: sum of 2 quarters · filed 2023-03-24 | $3.51M derived: sum of 3 quarters · filed 2023-03-24 | $3.90M 10-K · filed 2023-03-24 |
| 2021-09-30 | $3.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $4.49M derived: sum of 2 quarters · filed 2022-11-14 | $4.87M 10-Q · filed 2022-11-14 | $5.48M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.49M 10-Q · filed 2022-08-12 | $2.09M derived: sum of 3 quarters · filed 2022-08-12 | $2.31M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $387.00K 10-Q · filed 2022-05-13 | $992.00K derived: sum of 2 quarters · filed 2022-05-13 | $1.20M derived: sum of 3 quarters · filed 2022-05-13 | -$1.44M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $605.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $817.00K derived: sum of 2 quarters · filed 2022-03-11 | -$1.83M derived: sum of 3 quarters · filed 2022-03-11 | -$2.60M 10-K · filed 2022-03-11 |
| 2020-09-30 | $212.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$2.44M derived: sum of 2 quarters · filed 2021-11-12 | -$3.21M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$2.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$3.42M 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$770.00K 10-Q · filed 2021-05-14 | |||
| 2019-09-30 | -$424.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$63.00K derived: sum of 2 quarters · filed 2020-11-12 | $717.00K 10-Q · filed 2020-11-12 | $1.16M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $361.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $1.14M 10-Q · filed 2020-08-13 | $1.58M derived: sum of 3 quarters · filed 2020-08-13 | $1.47M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $780.00K 10-Q · filed 2020-05-14 | $1.22M derived: sum of 2 quarters · filed 2020-05-14 | $1.10M derived: sum of 3 quarters · filed 2020-05-14 | $1.57M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $324.00K derived: sum of 2 quarters · filed 2019-11-14 | $787.00K derived: sum of 3 quarters · filed 2019-11-14 | $368.00K 10-K · filed 2019-04-01 |
| 2018-09-30 | -$115.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $348.00K derived: sum of 2 quarters · filed 2019-11-14 | -$71.00K 10-Q · filed 2019-11-14 | -$113.00K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $463.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $44.00K 10-Q · filed 2019-08-09 | $2.00K derived: sum of 3 quarters · filed 2019-08-09 | $1.61M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | -$419.00K 10-Q · filed 2019-05-15 | -$461.00K derived: sum of 2 quarters · filed 2019-05-15 | $1.14M derived: sum of 3 quarters · filed 2019-05-15 | $911.00K derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | -$42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $1.56M derived: sum of 2 quarters · filed 2019-04-01 | $1.33M derived: sum of 3 quarters · filed 2019-04-01 | $1.09M 10-K · filed 2019-04-01 |
| 2017-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.37M derived: sum of 2 quarters · filed 2018-11-09 | $1.14M 10-Q · filed 2018-11-09 | $2.04M derived: sum of 4 quarters · filed 2018-11-09 |
| 2017-06-30 | -$232.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-08 | -$469.00K 10-Q · filed 2018-08-08 | $435.00K derived: sum of 3 quarters · filed 2018-08-08 | $133.00K derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | -$237.00K 10-Q/A · filed 2018-08-08 | $667.00K derived: sum of 2 quarters · filed 2018-08-08 | $365.00K derived: sum of 3 quarters · filed 2018-08-08 | $1.29M derived: sum of 4 quarters · filed 2018-08-08 |
| 2016-12-31 | $904.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $602.00K derived: sum of 2 quarters · filed 2018-02-23 | $1.53M derived: sum of 3 quarters · filed 2018-02-23 | $2.27M 10-K · filed 2018-02-23 |
| 2016-09-30 | -$302.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $623.00K derived: sum of 2 quarters · filed 2017-11-13 | $1.36M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | $925.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $1.67M 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | $740.00K 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |